Skip to main navigation Skip to search Skip to main content

Nanocomposite of reduced nanographene oxide with β-lactoglobulin protein (rNGO/β-Lg) as a carrier of the anticancer drug oxaliplatin (Eloxatin)

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Nanocomposite of reduced nanographene oxide with β-lactoglobulin protein (rNGO/β-Lg) as a carrier of the anticancer drug oxaliplatin (Eloxatin)'. Together they form a unique fingerprint.
Sort by

Material Science